NEW BRUNSWICK, N.J., April 4, 2005 /PRNewswire-FirstCall via COMTEX/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has completed its acquisition of TransForm Pharmaceuticals, Inc., a Lexington, Massachusetts based company specializing in the discovery of superior formulations and novel crystalline forms of drug molecules. The transaction was completed as announced on March 9, 2005.
Johnson & Johnson, through its operating companies, is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 200 operating companies employ approximately 109,900 men and women in 57 countries and sell products throughout the world.
SOURCE Johnson & Johnson
Press, Ernie Knewitz, +1-908-927-2953, Marc Monseau, +1-732-524-1130, or Investor, Helen E. Short, +1-732-524-6491, Stan Panasewicz, +1-732-524-2524, all of Johnson & Johnson
Copyright (C) 2005 PR Newswire. All rights reserved.
News Provided by COMTEX